394 related articles for article (PubMed ID: 31376068)
1. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.
Singh SK; Srivastav S; Castellani RJ; Plascencia-Villa G; Perry G
Neurotherapeutics; 2019 Jul; 16(3):666-674. PubMed ID: 31376068
[TBL] [Abstract][Full Text] [Related]
2. Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.
Shi C; Liu J; Wu F; Yew DT
Int J Mol Sci; 2010 Jan; 11(1):107-23. PubMed ID: 20162004
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?
Ramassamy C; Longpré F; Christen Y
Curr Alzheimer Res; 2007 Jul; 4(3):253-62. PubMed ID: 17627482
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract.
Luo Y
Life Sci; 2006 Mar; 78(18):2066-72. PubMed ID: 16507312
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer's disease.
Assi AA; Farrag MMY; Badary DM; Allam EAH; Nicola MA
Inflammopharmacology; 2023 Jun; 31(3):1449-1464. PubMed ID: 36856916
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease.
Zimmermann M; Colciaghi F; Cattabeni F; Di Luca M
Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):613-23. PubMed ID: 12396071
[TBL] [Abstract][Full Text] [Related]
8. Can We Use
Xie L; Zhu Q; Lu J
Cells; 2022 Jan; 11(3):. PubMed ID: 35159288
[TBL] [Abstract][Full Text] [Related]
9.
Peng Y; Chen Q; Xue YH; Jin H; Liu S; Du MQ; Yao SY
Am J Chin Med; 2024; 52(3):625-666. PubMed ID: 38654507
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Mazza M; Capuano A; Bria P; Mazza S
Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba leave extract: biological, medicinal, and toxicological effects.
Chan PC; Xia Q; Fu PP
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):211-44. PubMed ID: 17763047
[TBL] [Abstract][Full Text] [Related]
13. [Use of special Ginkgo biloba extract for cognitive disorders in the elderly].
Simányi M
Wien Med Wochenschr; 1999; 149(8-10):231-4. PubMed ID: 10483688
[TBL] [Abstract][Full Text] [Related]
14. Review about Ginkgo biloba special extract EGb 761 (Ginkgo).
Gertz HJ; Kiefer M
Curr Pharm Des; 2004; 10(3):261-4. PubMed ID: 14754386
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Tian J; Liu Y; Chen K
Curr Vasc Pharmacol; 2017; 15(6):532-548. PubMed ID: 28707602
[TBL] [Abstract][Full Text] [Related]
16. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.
Oken BS; Storzbach DM; Kaye JA
Arch Neurol; 1998 Nov; 55(11):1409-15. PubMed ID: 9823823
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
McKenna DJ; Jones K; Hughes K
Altern Ther Health Med; 2001; 7(5):70-86, 88-90. PubMed ID: 11565403
[TBL] [Abstract][Full Text] [Related]
19. Oral Supplements of
Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Exploration of the Neuroprotective Mechanisms of
Liu Q; Wang J; Gu Z; Ouyang T; Gao H; Kan H; Yang Y
Am J Chin Med; 2024 Jun; ():1-34. PubMed ID: 38904550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
